Helicobacter pylori-related gastroenterology studies

Helicobacter pylori is a bacterial pathogen that colonizes the stomach lining in roughly half the world's population and remains the leading known cause of gastric cancer, a malignancy that kills nearly a million people each year. Researchers study how the infection triggers chronic inflammation, damages mucosal tissue, and interacts with host genetic factors — such as polymorphisms in the interleukin-1 gene cluster — to push some patients toward cancer while others remain largely unaffected. A central challenge is that antibiotic resistance is eroding the effectiveness of standard eradication regimens, making it urgent to identify which drug combinations work in which populations and at what stage of disease progression intervention still prevents malignancy. Open questions center on whether widespread eradication programs would meaningfully reduce cancer incidence at a population level and how surgical management should be tailored for patients whose disease has already advanced despite treatment.

Works

155,622

Total citations

2,211,401

Keywords

Gastric CancerHelicobacter pyloriInflammationAntibiotic ResistanceEradication TherapyPathogenesis